Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
AB Akola Group Invitation to the 9M 2025/2026 Financial Results Webinar
-
GIP Moves from Supporting Role to Key Variable: BrightGene Bio-Medical's Phase III Results Signal Differentiation in Weight Loss Arena
-
DSV, 1169 - DSV ANNOUNCES UPDATED STRATEGIC PRIORITIES AND NEW FINANCIAL TARGETS FOR 2030 AT ITS CAPITAL MARKETS DAY
-
Director Change
-
QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting
-
Lone Star Funds Completes Acquisition of DOMO Engineered Materials
-
Merz Therapeutics’ Activities at ISPRM 2026 Highlight the Importance of Patient-Centric Management in Upper and Lower Limb Spasticity: From Goal Setting to Optimal Dosing for Better Patient Outcomes
-
TotalEnergies SE: Disclosure of Transactions in Own Shares
-
Rompower Energy Systems Inc Invites You to PCIM 2026 Seminars
-
Best’s Market Segment Report: AM Best Revises Outlook on Italy’s Life Insurance Segment to Stable From Negative
-
Netmore Announces Strategic Collaboration with Green Frog Asset Management and Sensational Systems to Deliver Smart Gas Metering Solution
-
Bindex brings osteoporosis screening to Boots pharmacies
-
Rexel: Acquisition of Revere Electrical Supply, expanding Rexel’s US footprint
-
Sword Group: Acquisition in the UK - New Strategic Acquisition in Scotland Complementary « multi-hybrid cloud computing » skills
-
Novo Nordisk A/S: Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity
-
NBPE Announces Transaction in Own Shares
-
Transaction in Own Shares
-
Infex Therapeutics secures £4.3 million funding to advance anti-infective pipeline targeting drug-resistant infections
-
Progress on share buyback programme
-
Elis: Disclosure of trading in own shares occured from May 4 to May 8, 2026
-
Agronomics Limited leads US$5m Investment in SuperMeat
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares
-
ichi Antiquite's Botanical Print Shirt Illustrates Refined Natural Elegance, Introduced by miel
-
Agfa-Gevaert delivers robust Q1 2026 performance amid market challenges
-
SES Delivers Robust Q1 2026 Results & Reiterates Full-Year Outlook
-
Coloplast A/S - Announcement no. 05/2026 - Interim Financial Report, H1 2025/26
-
Toobit Celebrates Bitcoin Pizza Day with 100,000 USDT Rewards, BTC Airdrops, and Trade Protection
-
Brunel Capital Markets Day 2026: Stronger foundations. Clear path to growth. Ready to scale.
-
Flow Traders Capital Markets Day
-
MindMaze Therapeutics and Vibra Healthcare Sign Definitive Channel Partnership Agreement to Scale Advanced Neurotherapeutics Across the U.S.
-
SHIB Price Prediction Signals Recovery, but Pepeto Shows Long-Term Moonshot Potential
-
JCB and Credit Card Association of the Philippines (CCAP) Launch Partnership to Boost Financial Literacy Among Filipinos
-
U.S. Postal Service to Honor Nation's 250th Anniversary With American Icons Stamps Curated by Ralph Lauren
-
Bloomsbury Money Secures Money Service Business (e-money) License in Jersey
-
Number of Shares and Voting Rights of Innate Pharma as of April 16, 2026
-
Start of Day Message
-
LHV Group results in April 2026
-
EfTEN Real Estate Fund AS – Four-Month financial results 2026 and net asset value as of 30 April 2026
-
Hexagon Purus ASA: Results for the first quarter 2026
-
KBC Group: First-quarter result of 557 million euros
-
MARTELA CORPORATION’S INTERIM REPORT 1 JANUARY – 31 MARCH 2026
-
Weekly progress on share repurchase program to cover share plans and reduce capital
-
Roche receives CE mark for new blood test to detect Alzheimer's pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217)
-
Nedap expands presence in Saudi Arabia with new office
-
Zenith Capital Corp. Amends Promissory Notes
-
Lerøy Seafood Group ASA: Q1 2026 Results
-
Q1 2026 Update: Tecan on track with low-single-digit local currency growth in Q1; full-year 2026 outlook confirmed
-
Hengrui Pharma and Bristol Myers Squibb Announce Strategic Agreements to Advance Innovative Medicines Across Oncology, Hematology, and Immunology
-
Tyler Technologies, Inc. Prices Upsized Offering of $1.25 Billion Convertible Senior Notes due 2031
-
KeyCrew Media Names Daniel Kaufman a Verified Expert in Contrarian Real Estate

